In this study, we obtained over 4,000 transposon mutants of Mycobacterium vanbaalenii PYR-1 and analyzed one of the mutants, 8F7, which appeared to lose its ability to degrade pyrene while still being able to degrade fluoranthene. This mutant was identified to be defective in nidA, encoding an aromatic ring-hydroxylating oxygenase (RHO), known to be involved in the initial oxidation step of pyrene degradation. When cultured with pyrene as a sole source of polycyclic aromatic hydrocarbon (PAH), high-pressure liquid chromatography analysis revealed that the nidA mutant showed a significant decrease in the rate of pyrene degradation compared to the wild-type PYR-1, although pyrene was still being degraded. However, when incubated with PAH mixtures including pyrene, phenanthrene, and fluoranthene, the pyrene degradation rate of the mutant was higher than that of the mutant previously incubated with pyrene as a sole source of PAH. There was no significant difference between wild-type PYR-1 and the mutant in the rates of phenanthrene and fluoranthene degradation. From the whole-cell proteome analysis of mutant 8F7 induced by pyrene, we identified expression of a number of RHO enzymes which are suspected to be responsible for pyrene degradation in the nidA mutant, which had no expression of NidA. Taken together, results in this study provide direct evidence for the in vivo functional role of nidA in pyrene degradation at the level of the ring-cleavage-process (RCP) functional module but also for the robustness of the PAH metabolic network (MN) to such a genetic perturbation.
M
ycobacterium vanbaalenii PYR-1 (10, 18) was originally isolated from oil-contaminated sediment by virtue of its ability to metabolize pyrene (5) . Because of its metabolic versatility to mineralize or degrade various polycyclic aromatic hydrocarbons (PAHs), including biphenyl, naphthalene, anthracene, fluoranthene, 1-nitropyrene, phenanthrene, benzo[a]pyrene, benz [a] anthracene, and 7,12-dimethylbenz [a] anthracene (5, 6, 8, 9, (29) (30) (31) , M. vanbaalenii PYR-1 has been extensively studied as a prototype organism for bacterial PAH metabolism, with special emphasis on high-molecular-weight (HMW) PAHs with four or more fused aromatic rings (13, 14, 23) .
The ability of M. vanbaalenii PYR-1 to degrade various aromatic hydrocarbons has been attributed in some degree to the presence of redundant genes for the degradation of PAHs (16) . In particular, 21 genes encoding ring-hydroxylating oxygenase (RHO), which often initiates aerobic degradation of aromatic compounds by catalyzing the insertion of molecular oxygen into the aromatic ring, were identified in the genome of M. vanbaalenii PYR-1. Among these RHO genes, nidA (11) has been proposed to be involved in the degradation of pyrene because the gene is upregulated by pyrene (11, 17) and the enzyme NidA has the highest transformation activity toward pyrene (24) . Since we initially identified and characterized nidA (11) , homologous genes with high levels of similarity to nidA have repeatedly been identified among mycobacteria isolated from geographically diverse environmental locations (1, 21, 28, 32, 34) . Studies have also proposed that this gene plays an important role in the degradation of HMW PAHs, and thus, it has even been used as a marker in molecular ecological studies to monitor PAH degradation in the environment (2, 3) . However, although nidA was functionally and regulatorily connected to pyrene degradation, no direct evidence with respect to its actual cellular function has ever been proposed.
Recently, we reconstructed a PAH metabolic network (MN) in M. vanbaalenii PYR-1, based on its genome sequence and polyomic data (15, 17, 26) , which allowed us to formulate a systematic insight into the mechanism of bacterial PAH degradation at the level of the MN (25) . According to the PAH-MN, PAH substrates are degraded by a set of interconnected functional processes or modules, termed ring-cleavage processes (RCPs), side chain processes (SCPs), and central aromatic processes (CAPs). For example, degradation of pyrene, which is mainly initiated by C-4,5 dioxygenation to form pyrene cis-4,5-dihydrodiol by O 2 -dependent RHO enzymes, is ring cleaved in the RCP functional module via a dihydrodiol dehydrogenase and a ring-cleavage dioxygenase. Then, the SCP functional module is followed, in which side chains of the ring-cleavage product are processed, and this produces metabolites for another round of RCP as well as molecules of biological precursors, such as pyruvate. The SCP and RCP functional modules repeat until the pathway reaches protocatechuate to enter CAP, which is finally channeled through the ␤-ketoadipate pathway into the tricarboxylic acid (TCA) cycle (25) .
Among the three functional modules, RCP primarily determines the range of substrates and their degradation pathways in the PAH-MN. Unlike SCP and CAP enzymes, RCP enzymes are mostly regulated depending on the type of aromatic substrate. When M. vanbaalenii PYR-1 is exposed to pyrene, the RCP enzyme NidA is upregulated and guides the degradation of pyrene exclusively into the dioxygenation route at the pyrene C-4,5 positions, which is the only productive way for pyrene to be channeled into the TCA cycle (17, 25) . Pyrene can also be degraded by M. vanbaalenii PYR-1 through the C-1,2 dioxygenation route to O-methylated dead-end metabolites. Therefore, if we look at the results from enzyme-based bottom-up analysis in terms of functional modules, it appears that the PAH-MN is probably less tolerant toward an error(s) in the functional modules than expected from the metabolite-centric robustness of the PAH-MN.
In the study described in this paper, we have investigated the response of the PAH-MN to a genetic perturbation via its functional modules to understand how the function of a module or the entire PAH-MN can be derived from the functions of its components. To exclude any bias, we adopted a forward genetic mutagenesis approach, using a Tn5-based transposon system to introduce into the functional module a genetic perturbation based on an impaired ability of M. vanbaalenii PYR-1 to degrade PAH substrates. Among over 4,000 M. vanbaalenii PYR-1 transformants, we selected a mutant, designated 8F7, which appeared to lose its ability to degrade pyrene while still being able to degrade fluoranthene. The mutant 8F7 was shown to be defective in the RCP gene nidA, encoding the RHO enzyme, which is essential for the metabolism of pyrene in strain PYR-1. By comparative analysis between the wild-type strain PYR-1 and the nidA mutant 8F7, we examined the functional contribution of nidA to the RCP functional module in the metabolism of a single source of PAH, including pyrene, phenanthrene, and fluoranthene. To further understand the function and genetic perturbation effect of nidA at the level of PAH-MN, we conducted another PAH degradation study, using mixtures of pyrene, phenanthrene, and fluoranthene. We then analyzed the proteome of the mutant incubated with pyrene and compared its expression profile with the previously reported profile from the pyrene-exposed wild-type strain PYR-1 to understand the molecular background of PAH degradation. In this investigation, we provide direct evidence for the in vivo functional role of nidA in the degradation of PAHs at the level of the RCP functional module. We also report that the PAH-MN is robust to this genetic perturbation.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and chemicals. M. vanbaalenii PYR-1 and mutant cultures were grown at 30°C in Luria-Bertani (LB) medium or Middlebrook 7H9 medium supplemented with oleic acidalbumin-dextrose-catalase enrichment (Remel, Lenexa, KS). Media were solidified with 1.5% agar, and kanamycin (25 to 50 g/ml) was added when needed. For the test of PAH degradation, supplemented minimal medium (SMM) with or without glucose (12) was used with slight modifications. Pyrene and phenanthrene were purchased from Chem Service (West Chester, PA). Fluorene, anthracene, fluoranthene, benz[a]anthracene, benzo[a]pyrene, and kanamycin were purchased from Sigma-Aldrich (St. Louis, MO). PAHs were dissolved in dimethyl sulfoxide (100 mM) or N,N-dimethylformamide (250 mM to 1 M) and added to culture flasks containing SMM with various concentrations of PAHs as required. PAHs were dissolved in acetone (1%, wt/vol) for the selection of mutant strains by the spray method (20) . Cell growth was determined by measuring the increase in optical density at 600 nm (OD 600 ) with a Synergy 2 microplate reader (BioTek Instruments, Winooski, VT). Each kinetic value of PAH degradation is the mean of triplicate independent experiments. To prepare electrocompetent cells, a flask containing 20 ml of LB broth inoculated with a single colony of strain PYR-1 was grown for 3 to 5 days with shaking for a start culture. The culture was then transferred into 200 ml of LB broth containing 0.05% Tween 80 and further incubated with shaking for 1 day. To increase transformation efficiency, filter-sterilized isonicotinic acid hydrazide was added to a final concentration of 4 g/ml (7) when the culture reached an OD 600 of 0.5 to 0.7 and the culture was incubated for another 4 h. The culture was pelleted at 4°C, washed twice with cold 10% filter-sterilized glycerol, and finally resuspended in 1/100 of the original culture volume in cold 10% glycerol. Aliquots of 85 l were then stored at Ϫ70°C.
Construction of transposon mutants. The M. vanbaalenii PYR-1 mutants were constructed by using an EZ::TN5 ϽR6K␥ori/KAN-2ϾTnp transposome kit (Epicenter Biotechnologies, Madison, WI) on the basis of the manufacturer's recommendation. For transformation, electrocompetent wild-type M. vanbaalenii cells mixed with 1 l of the transposome were kept on ice for 10 min and transferred into a prechilled 0.1-cm electrode spacing cuvette (Bio-Rad, Hercules, CA). Electroporation was conducted using a BTX electroporator (ECM 630; Harvard Apparatus, Holliston, MA) at settings of 2.4 kV, 200 ⍀, and 25 F for a 4-to 6-ms pulse duration, and then 1 ml of 7H9 broth containing 0.05% Tween 80 was added. After 4 h of incubation with shaking in a 50-ml culture tube, an appropriate volume of the cell culture was spread on Middlebrook 7H9 agar plates containing 25 g/ml of kanamycin and 100 g/ml of cycloheximide and incubated for 5 days to allow formation of colonies. To confirm transposition, we tested randomly picked colonies by PCR using the KAN-2 FP-1 forward primer (5=-ACCTACAACAAAGCTCTCATCA ACC-3=) and the R6KAN-2 RP-1 reverse primer (5=-CTACCCTGTGGA ACACCTACATCT-3=) provided by the transposon manufacturer. Briefly, mutant candidates were picked into a microtube containing 50 l of lysis buffer (1% Triton X-100, 20 mM Tris-HCl, pH 8.0, 2 mM EDTA) and boiled for 10 min. The supernatant was used directly for amplification with Ex Taq polymerase (TaKaRa, Madison, WI). PCR conditions were as follows: denaturation at 95°C for 2 min and 30 cycles each consisting of 95°C for 1 min, 58°C for 1 min, and 72°C for 1.5 min, with a final elongation step at 72°C for 7 min. We picked all colonies for further evaluation in 7H9 agar plates and stored them in 10% glycerol-containing 96-well plates at Ϫ70°C.
Mutant screens. The transformed M. vanbaalenii PYR-1 mutant candidates were replicated, using a microplate replicator, on the surface of 150-mm-diameter 7H9 agar plates from 96-well plates and incubated for 10 days. Plates were then sprayed with a 1% PAH solution and incubated for 2 to 3 days to recognize a clear zone or halo around colonies in the film of PAHs. We determined transposon integration sites by plasmid rescue cloning according to the manufacturer's recommendation. Briefly, selfligated SacII-digested genomic DNA was isolated using an Ultraclean microbial DNA isolation kit (Mo Bio Laboratories, Carlsbad, CA), and it was transformed into TransforMax EC100D pir-116 electrocompetent Escherichia coli (Epicenter Biotechnologies), followed by selection on 7H9 agar plates containing 50 g/ml of kanamycin. Plasmid DNA was purified using a QIAquick plasmid miniprep kit (Qiagen, Valencia, CA). Sequences were determined using the facility at the University of Arkansas for Medical Sciences (Little Rock, AR).
Analytical methods. Cultures of each sample (1.5 ml) were directly extracted three times with equal volumes of ethyl acetate. Residual water in the extracted fraction was removed by addition of sodium sulfate. The solvent was evaporated in vacuo, and the residues were dissolved in acetonitrile. Sequentially, a 10-l filtrate was subjected to high-pressure liquid chromatography (HPLC) analysis using an 1100 series HPLC (Agilent Technologies, Santa Clara, CA). The mobile phase consisted of two step gradients, for 10 min with 10 to 30% acetonitrile in water with constant 0.1% formic acid and for 30 min with 30 to 100% acetonitrile in water with constant 0.1% formic acid at a flow rate of 0.3 ml min Ϫ1 , followed by 100% acetonitrile for 10 min at a flow rate of 0.5 ml min Ϫ1 . The diodearray detector signal was monitored at 240, 254, 270, 280, 290, 300, 330, and 348 nm with a reference wavelength of 360 nm.
Proteome analysis. The whole-cell proteome of the mutant 8F7 was analyzed as described previously for the wild-type strain M. vanbaalenii PYR-1 (25) . Briefly, mutant cells were induced with pyrene 3 times at 24-h intervals, and proteins were extracted using glass bead homogenization. After SDS-PAGE, gels were cut into 40 equal bands and in-gel-trypsindigested peptides were extracted from each gel band. The peptide mixtures were analyzed by reversed-phase nanoflow liquid chromatographytandem mass spectrometry (RP nanoLC-MS/MS) using an Agilent 1200 nanoLC system (Agilent Technologies) coupled online to a linear ion trap mass spectrometer (LTQ XL; Thermo Fisher Scientific, Waltham, MA). Quantitative changes for samples of the mutant strain from the wild-type strain PYR-1 were estimated by comparing peptide peak area normalized to the total areas of all the peptides identified from each experiment. The quality and quantity of the whole-cell proteome of the mutant 8F7 were evaluated with the previous proteomic data of M. vanbaalenii PYR-1. For detailed information on proteomics and statistical analysis, refer to the paper by Kweon et al. (25) .
RESULTS
Construction of a mutant library and isolation of a nidA mutant. Because M. vanbaalenii PYR-1 is refractory to genetic manipulation due to the presence of a thick and waxy cell wall, a well-known trait of the genus Mycobacterium, it was difficult for us to generate mutant candidates using methods recommended for the transformation of M. tuberculosis (4) . We did repeated trial-and-error studies balancing parameters until we had finally reached a satisfactory level of electroporation efficiency to generate thousands of mutants. We applied high field strength, 2.4 kV per millimeter cuvette gap, with high resistance of 200 ⍀, which is much higher than that which is recommended for M. tuberculosis (4) . The experimental conditions developed in this study may be helpful to other investigators to use as a reference method for other environmental mycobacterial strains or other nocardioform Actinobacteria.
The transposon mutagenesis experiment generated transposon-induced kanamycin-resistant mutants from M. vanbaalenii PYR-1. As experimental conditions were optimized, the transformation efficiency reached an average of 1 ϫ 10 2 to 2 ϫ 10 2 colonies in each electroporation experiment and often reached over 3 ϫ 10 2 colonies. PCR analysis on a number of randomly picked colonies confirmed that the colonies had genomic insertions. By further experimentation, we obtained over 4,000 individual mutant colonies from M. vanbaalenii PYR-1. We screened these mutants based mainly on changes in the mode of PAH degradation by using the PAH spray plate technique (20) . 7H9 replica agar plates, each containing 96 mutant candidates, were coated with fluorene, anthracene, phenanthrene, pyrene, or fluoranthene, and colonies were examined for zones of clearing and patterns of color development. This screening procedure yielded 43 mutants with such phenotypic changes ( Table 1) . We analyzed the sites of transposition insertion of these 43 mutants, with confirmation of 9-bp duplications of the insertion, typical of EZ::TN transposition, which allowed identification of the Mvan numbers originally assigned to each open reading frame (ORF) in the M. vanbaalenii PYR-1 genome sequence (http://img.jgi.doe.gov).
As shown in Table 1 , insertion of transposon produced quite a diverse genetic perturbation with respect to the mode of PAH metabolism. For example, among 43 mutants, 9 and 10 mutants appeared to have a mutation related to the degradation of pyrene and fluoranthene, respectively, and 13 mutants were defective in the degradation of both pyrene and fluoranthene. Mutants with impaired ability to degrade fluorene and anthracene were also found. Interestingly, among these mutants with changes in the mode of PAH degradation, sequencing results showed that only 7 mutants had transposon insertions in the genes located in the catabolic genomic island I (GI-I), which encode most of the enzymes involved in PAH degradation (16, 25) . Many other mutants were shown to have insertions in genes with functions not directly related to PAH degradation. As shown in Table 1 , we additionally screened 7 mutant candidates since they showed changes in the phenotype of colonies or rate of cell growth. For example, mutant 2G1 had a more than 2-fold increase in the size of colonies compared to wild-type PYR-1 and mutants W1 and W2 had colonies that were white instead of the typical yellow of the wild type.
Among these 43 mutant candidates, 1 mutant, designated 8F7, appeared to transform fluoranthene but not pyrene, and the sequence analysis revealed that the transposon had been inserted into the gene nidA, 1 of the 21 RHO genes of M. vanbaalenii PYR-1 ( Fig. 1 ). Since RHO is the first enzymatic step in the RCP functional module and the enzyme NidA was previously proposed to be involved in the initial oxidation of pyrene to pyrene cis-dihydrodiol, we assumed that a genetic perturbation had been introduced into the RCP functional module, responsible for pyrene degradation, and chose this mutant for further study.
Degradation of single PAHs by nidA mutant 8F7. Comparison of the growth characteristics of nidA mutant 8F7 versus those of wild-type strain PYR-1 revealed that their growth rates in 7H9 broth (data not shown) or SMM containing 1% glucose were almost the same (see Fig. S1A in the supplemental material). However, strain 8F7 showed diminished growth compared to that of wild-type PYR-1 when cells of the mutant were incubated in SMM supplemented with 2 mM pyrene without glucose addition (Fig.  2) . HPLC analysis revealed that while the culture of wild-type PYR-1 degraded over 95% of the pyrene within 5 days, cells of the mutant 8F7 showed no degradation of pyrene until about 13 days. Interestingly, however, strain 8F7 then initiated the degradation of pyrene, which reached a degradation level of 78% of the initial amount of pyrene by day 19. This result indicates that nidA is mainly involved in the degradation of pyrene but that other oxygenases are also probably involved in pyrene degradation.
Since the lower rate of pyrene degradation in the culture of the mutant was probably due to the difference in the rate of cell growth, we tested the pyrene degradability of the mutant with 1% glucose-added SMM containing 200 M pyrene, in which no growth difference from wild-type PYR-1 was found (see Fig. S1 in the supplemental material). In this experiment (Fig. 3) , as in the medium without glucose, wild-type PYR-1 degraded over 95% of the initial amount of pyrene within 4 days, but the mutant did not initiate pyrene degradation until day 7. The degradation of pyrene then started on day 8 and reached a level of 32% of the initial amount of pyrene added to the medium by the 10th day of incubation. This result confirms that the nidA gene is mainly responsible for the degradation of pyrene and that other alternative enzymes are also involved in the transformation of pyrene. When mutant and wild-type strains were incubated in a separate experiment with phenanthrene or fluoranthene as a sole source of PAH, there was no significant difference in the rate of phenanthrene or fluoranthene degradation (Fig. 3) . This result indicates that the inactivation of nidA function has little impact on the degradation of fluoranthene and phenanthrene.
Degradation of mixtures of PAHs by nidA mutant 8F7. We conducted another study with the nidA mutant 8F7, incubated with a mixture of PAHs, to see how much the degradation of PAHs depends on the function of NidA at the level of PAH-MN and how the behavior of the PAH-MN is affected by the loss of the nidA gene in terms of robustness in PAH metabolism. We found no significant difference in the rate of cell growth between the cells of mutant and wild-type strains incubated with the PAH mixture (see Fig. S2 in the supplemental material) . However, the wild-type strain PYR-1 degraded over 95% of the initial amount of pyrene added within 3 to 6 days, depending on the concentration in PAH mixtures, whereas a reduced rate of pyrene degradation was observed in the culture of the nidA mutant, which further indicated the involvement of nidA in the degradation of pyrene (Fig. 4) . Interestingly, however, unlike the incubation results of the mutant with pyrene as a sole PAH, we observed no delay in the degradation of pyrene. In addition, efficiency of pyrene degradation by the mutant was significantly higher than that from the mutant incubated with pyrene as a sole PAH. For example, on day 2, when the wild-type PYR-1 had degraded about 70% of the initial amount (66.7 M) of pyrene, strain 8F7 had degraded 29% of the initial pyrene (Fig. 4A) . In the other incubation medium with an elevated level of pyrene (200 M), whereas the wild-type bacterium had degraded over 90% of the initial pyrene on day 5, the mutant had degraded 60% of the pyrene over the same period. When the incubation time was prolonged up to 18 days, degradation of pyrene reached over 86% and 94% efficiency of the initial amount of pyrene for 200 M (each PAH concentration, 66.7 M) and 600 M (each PAH concentration, 200 M) PAH mixtures, respectively. These results not only further indicate the functional contribution of another oxygenase(s) to the degradation of pyrene but also suggest that the alternative oxygenase(s) is probably involved in the degradation of phenanthrene and fluoranthene. The rate of pyrene disappearance decreased at the time when phenanthrene and fluoranthene had been depleted from the incubation medium, indicating that the regulation of this other oxygenase(s) is probably affected by phenanthrene and fluoranthene. There seems to be no significant difference between wild-type PYR-1 and the mutant 8F7 in the patterns of disappearance of phenanthrene and fluoranthene. Proteome analysis of nidA mutant 8F7. To understand the effect of nidA genetic perturbation on the degradation of pyrene at the level of RCP from the perspective of protein expression, we conducted a whole-cell proteome analysis of the mutant incubated with pyrene and compared its profile of protein expression with that of the wild-type strain PYR-1 (25) . We also wanted to identify another alternative protein(s) potentially involved in the degradation of pyrene in the nidA mutant 8F7.
As shown in Table S1 in the supplemental material, we identified 1,806 proteins. Comparative analysis of protein expression profiles revealed that 1,442 proteins were shared among the mutant and wild-type PYR-1 strains and that 829 proteins were more than twice as abundant in the mutant as in wild-type PYR-1. Among about 200 genes initially proposed to be involved in PAH degradation (16), 24 proteins were more than twice as abundant in the amount of expression (Table 2 ). In particular, five RHO genes were identified to be expressed, of which four RHO enzymes, Mvan_0525 (nidA3), Mvan_0534, Mvan_0540, and Mvan_0546 (pdoA2), were significantly more abundant (9-, 9-, 6-, and 200-fold, respectively). Table 3 shows a comparison of the expression profiles of 21 RHO enzymes involved in initial ring hydroxylation of aromatic hydrocarbons during incubation of the wild-type strain PYR-1 and mutant 8F7 with PAHs. A gene encoding an O-methyltransferase protein (Mvan_0979) was also identified to be newly expressed in the mutant. Proteomic analysis indicated that the mutant 8F7 incubated with pyrene probably upregulated another alternative RHO enzyme system(s) in response to the unavailability of the main RHO enzyme NidA for pyrene degradation, which resulted in functional compensation for the degradation of pyrene.
DISCUSSION
The mutant 8F7 was identified to be defective in nidA, which encodes a type V RHO (22) . The gene nidA is involved in the initial step of RCP, an oxidoreduction process for the degradation of aromatic substrates to produce catechols and ring-cleavage products. Phylogenetically diverse aerobic bacteria follow the same metabolic logic for RCP reactions, with activation of the thermodynamically stable benzene rings being followed by ring cleavage (25) . Although RCP is nonproductive, preparing metabolites for the SCP and CAP functional modules, it is a crucial process that determines the substrate range and degradation pathway(s) (25) . Genes belonging to RCPs are mostly tightly regulated, depending on the substrates, compared to the genes involved in SCPs and CAPs. Permutations in enzyme distribution and regulation are also clearly substrate specific. In our prior study, channel manage- ment of strain PYR-1 in the degradation of PAHs at the level of PAH-MN has been suggested to control these permutations (25) . Considering the relatively diverse substrate acceptance of RCP, which produces relatively high-degree metabolites and highly branched pathways, RHOs are thought to most significantly affect the RCP functional module. Indeed, nidA is the most extensively studied gene among those related to bacterial HMW PAH metabolism. We believe that the knockout mutant 8F7, defective in the gene nidA, obtained by a forward genetics approach, was an ideal genetic perturbation model which experimentally allowed us to compare the response(s) of each degradation pathway and the PAH-MN to the genetic perturbation.
Among the 21 RHOs identified in the genome of strain PYR-1, the enzyme NidA has been suggested to be the main RHO responsible for the productive pathway involved in pyrene C-4,5 dioxygenation. Previously, experimental results indicated that the enzyme showed the highest substrate preference for pyrene, with exclusive product regiospecificity toward the formation of pyrene cis-4,5-dihydrodiol, suggesting pyrene-dependent regulation (17, 25) . The difference between wild-type strain PYR-1 and the mutant 8F7 in the rate of growth and pyrene degradation once again proved the enzyme NidA's pyrene-centric functional contribution. However, we observed that pyrene degradation did occur to a significant extent in incubations of the nidA mutant with pyrene, which provided direct experimental evidence for the involvement of another ring-hydroxylating enzyme(s) in the RCP for pyrene metabolism. As shown in the PAH-MN, oxidation of pyrene can be initiated by mono-and dioxygenation at positions C-1,2 and C-4,5 of pyrene and NidA can catalyze only the latter. In our proteome study, we identified 5 RHO enzymes when nidA mutant 8F7 was incubated with pyrene. Among them, 4 RHOs, Mvan_0525/0526 (NidA3B3), Mvan_0533/0534, Mvan_0539/0540, and Mvan_0546/0547 (PdoA2B2), were more abundant than those of wild-type strain PYR-1. Since NidA3 was previously shown to have catalytic ability to dioxygenate pyrene at both the C-1,2 and C-4,5 positions (24), these enzymes are thought to contribute to the disappearance of pyrene by the mutant, although the functional contribution of other expressed RHOs cannot be completely ruled out. However, the decrease in the rate of pyrene degradation in the mutant 8F7 compared to that of wild-type strain PYR-1 clearly indicates that the alternative enzyme system(s) is less effective than nidA.
The nidA genetic perturbation model provides another chance to elucidate the functional contribution of NidA to the RCPs in the metabolism of phenanthrene and fluoranthene. Degradation of phenanthrene by mycobacteria, including strain PYR-1, mainly occurs through C-3,4 hydroxylation (17, 21, 27, 33, 35, 36) . In addition to the C-3,4 pathway, as shown in Fig. 5 , M. vanbaalenii PYR-1 is also able to degrade phenanthrene via the C-1,2 and C-9,10 routes (19, 25) . Several lines of evidence have led us to suspect the involvement of NidA in the degradation of phenanthrene, which is an intermediate produced in pyrene degradation. First, NidA is upregulated by phenanthrene, in addition to pyrene (17, 25) . Second, NidA is able to dioxygenate phenanthrene at the C-3,4 and C-9,10 positions, although its activity with phenanthrene is only 75% of the pyrene transformation efficiency (24) . Unexpectedly, however, there was no distinct difference in the rate of phenanthrene degradation between cells of mutant and wildtype PYR-1. This observation indicates a minor contribution of NidA to phenanthrene metabolism (Fig. 5) . Involvement of another RHO(s), such as NidA3, in the dioxygenation of phenanthrene is also possible. NidA3 is expressed in the presence of phenanthrene and has phenanthrene hydroxylation activity (24) . With respect to the main C-3,4 dioxygenation for the degradation of phenanthrene, another RHO enzyme, PdoA2, has been proposed for this reaction. Previously, PdoA2 showed phenanthrenedependent regulation, an apparent substrate preference for phenanthrene, and product regiospecificity of phenanthrene cis-3,4-dihydrodiol (21) .
We observed no significant difference between strains 8F7 and PYR-1 in the rate of fluoranthene degradation, which indicates that nidA is probably not involved in the degradation of fluoranthene. This result is consistent with the previous proteome study showing that nidA was not induced by fluoranthene (26) .
Incubation experiments with each individual PAH allowed elucidation of the nidA function and its contribution to the degradation of single PAHs via the RCP functional module. On top of this observation, we expanded our efforts to identify the dependence of the PAH-MN on the function of NidA and the behavior of the PAH-MN with the loss of the nidA gene in terms of robustness in the metabolism of PAHs. To reduce unnecessary complexity of the PAH-MN, which might obscure functional modularity, and to keep realizable complexity at the level of PAH-MN, we designed an MN system using phenanthrene, pyrene, and fluoranthene.
Consistent with the results with pyrene as a sole source of PAH, the metabolism experiment with PAH mixtures showed the pyrene-centric function of NidA. Basically, both incubation conditions with a sole source of PAH and mixtures of PAHs indicated that the PAH-MN in M. vanbaalenii PYR-1 is functionally robust to such a genetic perturbation, which caused a malfunction of the RCP in the degradation of pyrene. However, incubation of the nidA mutant with mixtures of PAHs enhanced the rate of pyrene degradation with no lag in metabolism compared to incubation of the mutant with pyrene as a sole source of PAH. These results, as well as the previous studies on the NidA3 enzyme biochemistry, including substrate specificity and product regiospecificity (24) , provide new insights into the mechanism of pyrene degradation and its robustness in the bacterium in terms of metabolic efficiency at the level of PAH-MN. From the perspective of metabolic quantity, metabolism of pyrene in the PAH-MN appears to be robust. As shown in Fig. 4 , the disappearance of pyrene in the nidA mutant was significantly improved compared to that of strain 8F7 incubated with pyrene as a sole source of PAH. As illustrated in Fig. 5 , we suspect that NidA3 may be responsible for the robustness of the PAH-MN, based on the current and previous proteome studies (11, 15, 17, 25, 26) . As shown in Table 3 , M. vanbaalenii PYR-1 expresses more than 10 RHOs in different combinations in the presence of different PAHs. In particular, NidA3 is upregulated when the bacterium is exposed to fluoranthene. Interestingly, this RHO enzyme was identified in the mutant 8F7 to be upregulated more than 9-fold, relative to its abundance in strain PYR-1 ( Table 2 ). The observation that the rate of pyrene disappearance started to slow from the time point when the two PAH substrates, phenanthrene and fluoranthene, were depleted from the incubation medium also supports this hypothesis about NidA3 RHO-dependent robustness.
Degradation of pyrene in the PAH-MN appears to be robust in terms of metabolic quantity since the PAH substrate rapidly dissipated from the medium. Considering the efficiency of the rate of pyrene hydroxylation by NidA3, which is 57% of that of NidA (24) , the proposed NidA3-dependent robustness of the PAH-MN seems to be plausible. However, in qualitative metabolic terms, the NidA3-dependent robustness of pyrene degradation has a different aspect that should be considered. Whereas NidA produces exclusively pyrene cis-4,5-dihydrodiol, the NidA3 enzyme shows relatively low regiospecificity, producing both pyrene cis-1,2-dihydrodiol and cis-4,5-dihydrodiol (24) . Previously, we reported a complete pathway of pyrene degradation in which pyrene is initially hydroxylated at the C-4,5 positions and then degraded to the TCA cycle via protocatechuate (17) . However, if the initial hydroxylation occurs at position C-1,2, the degradation route goes through a detoxification step, producing dead-end products, Omethylated derivatives (17) . In analyzing the mutant proteome, we detected a new synthesis of an O-methyltransferase, which is potentially involved in this detoxification process (Table 2) . Taken together, it suggests that the NidA3-dependent robustness is probably less efficient in pyrene degradation in metabolic qualitative terms at the level of PAH-MN. As shown in Fig. 5 , NidA3 appears to be efficient in degrading pyrene in terms of quantity but produces a portion of metabolite that cannot be channeled through the pathway for further degradation. Further experimen- tal evidence is needed to determine the contribution(s) of an RHO(s) other than NidA3 and its influence on the quantity and quality of the robustness in the degradation of PAHs.
In conclusion, using the nidA genetic perturbation model, this study provides evidence of the pyrene-centric functional roles of nidA at the level of the RCP functional module in M. vanbaalenii PYR-1. Furthermore, we also report that the PAH-MN is robust to nidA genetic perturbation. It appears that the quantity and quality of the robustness are mainly dependent on the functional redundancy of the PAH-MN, which is linked to gene redundancy. We suggest that the robustness of the PAH-MN therefore depends on the location of perturbation on the functional modules and environmental transitions, which affect gene regulation.
